header

ReSHAPE PUBLICATIONS

  • Leila Amini, Jenny Greig, Michael Schmueck-Henneresse, Hans-Dieter Volk, Séverine Bézie, Petra Reinke, Carole Guillonneau, Dimitrios L Wagner, Ignacio Anegon.
    Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications.
    Frontiers in Immunology, 2021, 611638, DOI: 10.3389/fimmu.2020.611638. Open Access.
    → open it on the web
  • Maja Pizevska, Jaspal Kaeda, Enrico Fritsche, Hisham Elazaly, Petra Reinke, Leila Amini.
    Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective.
    Frontiers in Medicine, 2022, 757647, DOI:10.3389/fmed.2022.757647. Open Access.
    → open it on the web
  • Nadège Vimond, Juliette Lasselin, Ignacio Anegon, Carole Guillonneau, Séverine Bézie.
    Genetic engineering of human and mouse CD4+ and CD8+ Tregs using lentiviral vectors encoding chimeric antigen receptors.
    Molecular Therapy - Methods & Clinical Development, 2021, 69-85, DOI: 10.1016/j.omtm.2020.11.008. Open Access.
    → open it on the web
  • Laura Elisa Buitrago-Molina, Julia Pietrek, Fatih Noyan, Jerome Schlue, Michael P. Manns, Heiner Wedemeyer, Matthias Hardtke-Wolenski, Elmar Jaeckel.
    Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.
    Journal of Autoimmunity, 2021, 102591, DOI: 10.1016/j.jaut.2020.102591.
    → open it on the web
  • Daniel Kaiser, Natalie Maureen Otto, Oliver McCallion, Henrike Hoffmann, Ghazaleh Zarrinrad, Maik Stein, Carola Beier, Isabell Matz, Marleen Herschel, Joanna Hester, Guido Moll, Fadi Issa, Petra Reinke, Andy Roemhild.
    Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products ex vivo and in vivo.
    Frontiers in Cell and Developmental Biology, 2021, 750286, DOI: 10.3389/fcell.2021.750286.
    → open it on the web
  • Kristy Ou, Dania Hamo, Anne Schulze, Andy Roemhild, Daniel Kaiser, Gilles Gasparoni, Abdulrahman Salhab, Ghazaleh Zarrinrad, Leila Amini, Stephan Schlickeiser, Mathias Streitz, Jörn Walter, Hans-Dieter Volk, Michael Schmueck-Henneresse, Petra Reinke, Julia K Polansky.
    Strong Expansion of Human Regulatory T Cells for Adoptive Cell Therapy Results in Epigenetic Changes Which May Impact Their Survival and Function.
    Frontiers in Cell and Developmental Biology, 2021, 751590, DOI: 10.3389/fcell.2021.751590. Open Access.
    → open it on the web
  • Sybille Landwehr-Kenzel, Anne Zobel, Isabela Schmitt-Knosalla, Anne Forke, Henrike Hoffmann, Michael Schmueck-Henneresse, Robert Klopfleisch, Hans-Dieter Volk, Petra Reinke.
    Cyclosporine A but Not Corticosteroids Support Efficacy of Ex Vivo Expanded, Adoptively Transferred Human Tregs in GvHD.
    Frontiers in Immunology, 2021, 716629, DOI: 10.3389/fimmu.2021.716629. Open Access.
    → open it on the web
  • Dimitrios Laurin Wagner, Lena Peter, Michael Schmueck-Henneresse.
    Cas9-directed immune tolerance in humans-a model to evaluate regulatory T cells in gene therapy?
    Gene Therapy, 2021, 549-559, DOI: 10.1038/s41434-021-00232-2. Open Access.
    → open it on the web
  • Jonas Kath, Weijie Du, Bernice Thommandru, Rolf Turk, Leila Amini, Maik Stein, Tatiana Zittel, Stefania Martini, Lennard Ostendorf, Andreas Wilhelm, Levent Akyüz, Armin Rehm, Uta E. Höpken, Axel Pruß, Annette Künkele, Ashley M. Jacobi, Hans-Dieter Volk, Michael SchmueckHenneresse, Petra Reinke, Dimitrios L. Wagner.
    Fast, efficient and virus-free generation of TRAC-replaced CAR T cells.
    BioRxiv, 2021, DOI: 10.1101/2021.02.14.431017. Open Access.
    → open it on the web
  • Andy Roemhild, Natalie Maureen Otto, Guido Moll, Mohamed Abou-El-Enein, Daniel Kaiser, Gantuja Bold, Thomas Schachtner, Mira Choi, Robert Oellinger, Sybille Landwehr-Kenzel, Karsten Juerchott, Birgit Sawitzki, Cordula Giesler, Anett Sefrin, Carola Beier, Dimitrios Laurin Wagner, Stephan Schlickeiser, Mathias Streitz, Michael Schmueck-Henneresse, Leila Amini, Ulrik Stervbo, Nina Babel, Hans-Dieter Volk, Petra Reinke.
    Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial.
    British Medical Journal, 2020, DOI: 10.1136/bmj.m3734. Open Access.
    → open it on the web
  • Christopher Kressler, Gilles Gasparoni, Karl Nordström, Dania Hamo, Abdulrahman Salhab, Christoforos Dimitropoulos, Sascha Tierling, Petra Reinke, Hans-Dieter Volk, Jörn Walter, Alf Hamann and Julia K. Polansky.
    Targeted De-Methylation of the FOXP3-TSDR Is Sufficient to Induce Physiological FOXP3 Expression but Not a Functional Treg Phenotype.
    Frontiers in Immunology, 2021, 609891, DOI: 10.3389/fimmu.2020.609891. Open Access.
    → open it on the web
  • Christina Iwert, Julia Stein, Christine Appelt, Katrin Vogt, Roman Josef Rainer, Katja Tummler, Kerstin Mühle, Katarina Stanko, Julia Schumann, Doreen Uebe, Karsten Jürchott, Jan Lisec, Katharina Janek, Christoph Gille, Kathrin Textoris-Taube, Somesh Sai, Ansgar Petersen, Anja A. Kühl, Edda Klipp, Christian Meisel, Birgit Sawitzki.
    TCAIM controls effector T cell generation by preventing Mitochondria-Endoplasmic Reticulum Contact Site-initiated Cholesterol Biosynthesis.
    BioRxiv, 2021, DOI: 10.1101/2021.04.20.440500. Open Access.
    → open it on the web
  • Helen L. Stark, Hayson C. Wang, Jasmina Kuburic, Alaa Alzhrani, Joanna Hester and Fadi Issa.
    Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
    DOI https://doi.org/10.3389/fimmu.2021.664244.
    → open it on the web
  • Matthew J.Bottomley, Matthew O.Brook,Sushma Shankar, Joanna Hester, Fadi Issa.
    Towards regulatory cellular therapies in solid organ transplantation.
    DOI https://doi.org/10.1016/j.it.2021.11.001. NO Open Access.
    → open it on the web
  • Conor Hennessy, Guido Lewik, Amy Cross, Joanna Hester, Fadi Issa.
    Recent advances in our understanding of the allograft response.
    Faculty Reviews 2021, 10:21 DOI: https://doi.org/10.12703/r/10-21.
    → open it on the web
  • Sabrina Wright, Conor Hennessy,Joanna Hester, Fadi Issa.
    Chimeric Antigen Receptors and Regulatory T Cells: The Potential for HLA-Specific Immunosuppression in Transplantation.
    Engineering 2021 DOI https://doi.org/10.1016/j.eng.2021.10.018.
    → open it on the web
  • Alaa Alzhrani , Matthew Bottomley, Kathryn Wood, Joanna Hester, Fadi Issa.
    Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use. Cellular Immunology 2020, 357, 104214. DOI https://doi.org/10.1016/j.cellimm.2020.104214.
    → open it on the web
  • Léa Flippe, Séverine Bézie, Ignacio Anegon,vCarole Guillonneau.
    Future prospects for CD8+ regulatory T cells in immune tolerance.
    Immunological reviews, 2019, 292, 1-16, DOI: 10.1111/imr.12812.
    → open it on the web
  • Séverine Ménoret, Laure-Hélène Ouisse, Laurent Tesson, Séverine Remy, Claire Usal, Aude Guiffes, Vanessa Chenouard, Pierre-Joseph Royer, Gwenaelle Evanno, Bernard Vanhove, Eliane Piaggio, and Ignacio Anegon.
    In vivo analysis of human immune responses in immunodeficient rats.
    Transplantation, 2020, 104/4, 715-723, DOI: 10.1097/tp.0000000000003047.
    → open it on the web
  • George Adigbli, Séverine Ménoret, Amy R Cross, Joanna Hester, Fadi Issa, Ignacio Anegon.
    Humanization of immunodeficient animals for the modelling of transplantation, graft-versus host disease and regenerative medicine.
    Transplantation, ahead of print , DOI: 10.1097/tp.0000000000003177.
    → open it on the web
  • Enrico Fritsche, Hans-Dieter, Volk Petra Reinke, Mohamed Abou-El-Enein.
    Toward an optimized process for clinical manufacturing of chimeric antigen receptor regulatory T-cell therapy (CAR-Treg) Trends in Biotechnology.
    Trends in Biotechnology, 2020, 1-13 , DOI: 10.1016/j.tibtech.2019.12.009.
    → open it on the web
  • Enrico Fritsche, Magdi Elsallab, Michaela Schaden,Spencer Phillips Hey, Mohamed Abou-El-Enein.
    Post-marketing safety and efficacy surveillance of cell and gene therapies in the EU: A critical review.
    Cell & Gene Therapy Insights, 2019; 5(11), 1505–1521, DOI: 10.18609/cgti.2019.156.
    → open it on the web
  • Matthew Brook, Joanna Hester, Fadi Issa.
    New frontiers: cellular immunotherapy beyond cancer.
    Cell and Gene Therapy Insights, 2019, 1229-1236, DOI: 10.18609/cgti.2019.163.
    → open it on the web

ReSHAPE CONFERENCES

Type Researcher(s) involved Event (Title, location, dates) Activity title
(e.g. title of poster or talk, etc.)		 Type of audience Estimated persons reached
Participation to a conference P1 - Charité: L. Amini, Schmueck-Henneresse 1ST IMMUNOLOGY & INFLAMMATION CONFERENCE, 24. - 26.02. 2019 Immunosuppressant-resistant T cells for advanced adoptive T cell therapy in immunosuppressed patients Scientific Community (Higher Education, Research) >1000
Participation to an event other than a conference or workshop P1 - Charité: P. Reinke British German Alliance for Advanced Therapies, British Embassy, Berlin (Germany), 26.03.2019 ReSHAPE by next generation Treg approaches - An EU Consortium coordinated by BeCAT Policy Makers 53
Participation in activities organised jointly with other H2020 project(s) P1 - Charité: H.-D. Volk; P. Reinke Kick-off meeting of the RESTORE community, Berlin (Germany), 06.-07.05.2019 Promoting Advanced therapies and strenghten the development of Advanced Therapies in the European market Other >320
Participation to a conference P1 - Charité: L. Amini, Schmueck-Henneresse Allogenic Cell Therapies Summit, 7.-9.05.2019 Antiviral and CAR-T cell products for advanced adoptive T cell therapy Scientific Community (Higher Education, Research) >100
Participation to a conference P1 - Charité: P. Reinke; J. Wendering; L.Amini FOCIS Annual Meeting 2019, Boston (US), 18.-21.06.2019 Next-Generation Regulatory T Cell Therapy; The Value of a Rapid Test of Huamn Regulatory T Cell Function Needs to be Revised (poster) Scientific Community (Higher Education, Research) >1060
Participation to a conference P1 - Charité: L. Amini Cell & Gene Therapy Bioprocessing & Commercialization, 9.-12.09.2019   Investors >2000
Participation to a conference P1 - CHARITE: P. Reinke Phacilitate Leader Europe 2019, London (UK), 17.-18.09.2019 RESTORE/RESHAPE faces challenges in manufacturing of Advanced Therapies Scientific Community (Higher Education, Research) >350
Participation to a conference P1 - Charité: P. Reinke; L.Amini 7th Annual Conference of the German Stem Cell Network, Berlin (Germany), 23.-25.09.2019 Next-generation regulatory T cell products - opportunities and challenges Scientific Community (Higher Education, Research) >400
Participation to an event other than a conference or workshop P1 - Charité: P. Reinke Promoting Translational Research in University Medicine, Berlin (Germang), 08.12.2019 Early clinical trials with ATMPs Scientific Community (Higher Education, Research) >100
Participation to an event other than a conference or workshop P1 - Charité: P. Reinke; N. M. Otto, Schmueck-Henneresse RegMed Forum 2019: cell and gene therapies, Berlin (Germany), 22.10.2019 Regulatory T cells: A treatment option for balancing immune responses; Regulatory T cell therapy in solid organ transplantation; Other >120
Participation in activities organised jointly with other H2020 project(s) P1 - Charité: H.-D. Volk; P. Reinke; L. Amini, Schmueck-Henneresse RESTORE: 1st Advanced Therapy Science Meeting, Berlin (Germany), 25.-26.11.2019 RESTORE - Health by Advanced Therapies - Opportunities and Challenges; Reshape immune balance by next-generation regulatory T cells; Other 400
Participation to a conference P1 - Charité: Julia Polansky-Biskup RESTORE: 1st Advanced Therapy Science Meeting, Berlin (Germany), 25.-26.11.2019 invited talk: Epigenetic control of T cell differentiation: From genome-wide signatures to local regulators and their targeted manipulation. Scientific Community (Higher Education, Research) 400
Participation to a conference P1 - Charité: L. Amini, Schmueck-Henneresse The Hitchhiker’s Guide to Regenerative Therapies, 03.-06.12.2019 Immunosuppressant-resistant antiviral and regulatory T cell products for advanced adoptive T cell therapy in immunosuppressed patients Scientific Community (Higher Education, Research) >100
Brokerage event P1 - Charité: P. Reinke, H.-D. Volk Cooperation Meeting Lonza Therapeutics, 16.09.2020 T cell therapy/products Industry 4
Participation to a conference P1 - Charité: P. Reinke 29th Annual Meeting, German Transplantation Society (Deutsche Transplantationsgesellschaft / DTG), 17.10.2020 Presentation: T cell monitoring Scientific Community (Higher Education, Research) ca. 500
Brokerage event P1 - Charité: P. Reinke, H.-D. Volk Follow-up - Cooperation Meeting Charité - Lonza Therapeutics, 28.10.2020 T cell therapy/products Industry 7
Participation to a conference P1 - Charité: P. Reinke 20th Annual Meeting of the Federation of Clinical Immunology Societies, FOCIS, 30.10.2020 Presentation: ReSHAPE Undesired Immunoreaction in Transplantation Scientific Community (Higher Education, Research) >1000
Organisation of a Conference P1 - Charité: J. Polansky Symposium on "Epigenetic in Development and Regeneration", CRTD Dresden, 24.11.2020 From genome-wide signatures to local regulators and their targeted manipulation Scientific Community (Higher Education, Research) 80
Participation to an event other than a conference or workshop P1 - Charité: P. Reinke, M. Schmück-Henneresse, L. Amini, D. Wagner, A. Römhild, D. Kaiser, M. Abou El Enein, R. Öllinger, H.-D. Volk PEI (Paul Ehrlich Institut)- Scientif Advice Meeting, 12.11.2020 Next-Generation regulatory T cell (Treg) Product, TaRTreg01,using CRISPR-Cas9-mediated gene-editing technology Authory / Federal Institution 19
Participation on event other than a conference or workshop P1 - Charité: P. Reinke RegMed Forum 2020 - Viruses and heart diseases, 01.12.2020 Presentation: "Regulatory T-cells: a potential Treatment for inflammatory cardiomyopathy/myocarditis" other 100
Brokerage event P1 - Charité: P. Reinke Follow-up Meeting: Universitätsklinikum Leipzig, Leipzig (Germany), 03.12.2020 Next steps: ProTreg Study Importance of regulatory and antigen-specific T cells in kidney transplantation Scientific Community (Higher Education, Research) 5
Participation to a conference P1 - Charité: D.L. Wagner Keystone eSymposium: Precision Engineering of the Genome, Epigenome and Transcriptome | EK24 09.03.2021 Oral presentation, title: Fast and Efficient Generation of TRAC-integrated CAR T Cells without Viruses, Scientific Community (Higher Education, Research) >500
Brokerage event P1 - Charité: P. Reinke, D. Kaiser, A. Römhild, L. Amini, D. Wagner, M. Schmück-Henneresse, H.-D. Volk, E. Fritsche, J. Kaeda, H. Schmidts, J. Polansky Cooperation Meeting AstraZeneca, 18.03.2021 Treg cell therapy Industry 20
Participation to an event other than a conference or workshop P1 - Charité: P. Reinke KHP and EUHA "Meet the expert" global clinical seminar series, 30.03.2021 Presentation: Are regulatory T cells a realistic therapeutic option in solid organ transplantation? Scientific Community (Higher Education, Research) 55
Brokerage event P1 - Charité: P. Reinke, A. Römhild, D. Kaiser Cooperation Meeting CellCopedia, 13.04.2021 Development and marketing of medical technology for the selection of cells Industry 8
Brokerage event P1 - Charité: P. Reinke Ruhr-Universität Bochum, Bochum (Germany), kick off Meeting clin. Study Scientific Community (Higher Education, Research) 5
Brokerage event P1 - Charité: P. Reinke, H.-D. Volk Follow up Cooperation Meeting AstraZeneca, 12.05.2021 Treg strategy Industry 4
Brokerage event P1 - Charité: P. Reinke Cooperation Meeting Sarstedt, 20.05.2021 Discussion on the development of a monovette with AMG-compliant Na citrate for blood sampling for the production of cell products Industry 11
Brokerage event P1 - Charité: P. Reinke, L. Amini, H.-D. Volk, D. Wagner, D. Kaiser Follow up - Cooperation Meeting AstraZeneca, 26.05.2021 Treg strategy Industry 15
Brokerage event P1 - Charité: P. Reinke Follow up - Coorperation Meeting CellCopedia, CellDot, 07.06.2021 Development and marketing of medical technology for the selection of cells Industry 3
Participation to a conference P1 - Charité: J. Polansky Annual meeting german society for Immunology, clinical immunology, 23.06.2021 Utilizing epigenetics for the benefit of advanced therapies Scientific Community (Higher Education, Research) 60
Brokerage event P1 - Charité: P. Reinke, H.-D. Volk Follow up Coorperation Meeting CellCopedia, 28.06.2021 Development and marketing of medical technology for the selection of cells / discussion exploitation Industry 8
Brokerage event P1 - Charité: P. Reinke Cooperation Meeting Fraunhofer IBMT, 30.07.2021 cryoconservation regT Cells other 5
Brokerage event P1 - Charité: P. Reinke Coorperation Meeting Fraunhofer IBMT - UZ Leuven - Charité, 05.08.2021 project discussion T Cells other 14
Brokerage event P1 - Charité: P. Reinke, H.-D. Volk, A. Römhild, L. Amini, M. Schmück-Henneresse Follow up - Cooperation Meeting AstraZeneca, 09.09.2021 further discussion Treg strategy Industry 10
Brokerage event P1 - Charité: P. Reinke Follow up - Cooperation Meeting Fraunhofer IBMT, 14.09.2021 further steps, cryoconservation reg Te Cells other 2
Brokerage event P1 - Charité: P. Reinke Follow up Coorperation Meeting CellCopedia, 27.09.2021 Development and marketing of medical technology for the selection of cells / discussion exploitation Industry 2
Brokerage event P1 - Charité: P. Reinke, A. Römhild, D. Kaiser Follow up - Cooperation Meeting Fraunhofer IBMT, 28.09.2021 further steps, cryoconservation reg Te Cells other 6
Brokerage event P1 - Charité: P. Reinke, H.-D. Volk Cooperation Meeting Florabio, 11.10.2021 cell media development Industry 3
Participation to a conference P1 - Charité: P. Reinke Nederlandse Nefrologiedagen, 13.10.2021 Presentation: Are regulatory T cells a realistic option in solid organ transplantation ? Scientific Community (Higher Education, Research) >300
Brokerage event P1 - Charité: P. Reinke, D. Wagner Follow up - Cooperation Meeting LONZA, 14.10.2021 new technologies in manufactoring Treg Cells Industry 5
Participation to an event other than a conference or workshop P1 - Charité: D.L. Wagner Virtual World CRISPR Day 20.10.2021 Oral presentation, title: Engineering designer T cell immunotherapies for transplant medicine and oncology General Public >12000
Participation to a conference P1 - Charité: J. Kath Annual congress of the European Society for Gene and Cell Therapy 19-21.10.2021 Oral presentation, title: OR06: Improved non-viral CAR-reprogramming of human T cells using CRISPR-Cas and double-stranded DNA Scientific Community (Higher Education, Research) + Industry >600
Participation to an event other than a conference or workshop P1 - Charité: M. Schmueck-Henneresse Berlin Science Week: CELLS - MEDICINE OF THE FUTURE?, 12.11.2021 Oral presentation: With immune cells against diseases General Public >100
Brokerage event P1 - Charité: P. Reinke, A. Römhild Follow up - Cooperation Meeting Fraunhofer IBMT, 15.11.2021 further steps, cryoconservation reg Te Cells other 5
Brokerage event P1 - Charité: P. Reinke, A. Römhild, L. Amini, D. Wagner Follow up - Cooperation Meeting AstraZeneca, 17.11.2021 discussion on structuring collaboration Industry 10
Participation to a conference P1 - Charité: P. Reinke Workshop Focis Goes South 2021, 17.11.2021 "Presentation: Are regulatory T cells a realistic therapeutic option in solid organ transplantation?" Scientific Community (Higher Education, Research) >500
Organisation of a Conference P1 - Charité: D.L. Wagner RegMed Forum 2021, The multifaceted potential of CRISPR-Cas9 in medicine, Berlin (Germany) 25.11.2021 CRISPR-Cas9 for basic research and cell therapy applications Scientific Community (Higher Education, Research) + Industry >100
Participation to a conference P1 - Charité: L. Amini, Schmueck-Henneresse, D.L. Wagner RegMed Forum 2021, The multifaceted potential of CRISPR-Cas9 in medicine, Berlin (Germany) 25.11.2021 Oral presentations: TacRes Tregs, The Evolution of CRISPR-Cas9 technology Scientific Community (Higher Education, Research) + Industry >100
Brokerage event P1 - Charité: P. Reinke, A. Römhild, D. Kaiser Follow up - Cooperation Meeting Fraunhofer IBMT, 29.11.2021 further steps, cryoconservation reg Te Cells other 6
Participation to a conference P1 - Charité: L. Amini, M. Schmück-Henneresse, G. Zarrinrad Adeep dive into science, Berlin, 29.11.-02.12.2021 Oral presentation: A new generation of tacrolimus-resistant regulatory T cell products for advanced adoptive T cell therapy in solid organ transplantation Scientific Community (Higher Education, Research) >100
Brokerage event P1 - Charité: P. Reinke Follow up - Cooperation Meeting Charité - Lonza Therapeutics, 01.12.2021 new technologies in manufactoring Treg Cells Industry 2
Brokerage event P1 - Charité: P. Reinke, A. Römhild, L. Amini, D. Wagner Follow up - Cooperation Meeting AstraZeneca, 14.12.2021 further steps discussion on structuring collaboration Industry 2
Participation to a conference P1 - Charité: B. Sawitzki BIH Welcome Symposium, Berlin - online meeting, 15.12.2021 Strategies to increase Treg stability Scientific Community (Higher Education, Research) 100
Brokerage event P1 - Charité: P. Reinke, A. Römhild, L. Amini, D. Wagner Follow up - Cooperation Meeting AstraZeneca, 20.12.2021 Treg manufactoring Industry 2
Participation to a conference P1 - Charité: Leila Amini NAT & IGO virtual meeting: "New horizons in immunotherapy", online, May 31st and June 1st, 2021 Oral presentation: Immunosuppressant-resistant T cell products for improved functionality in immunosuppressed patients Scientific Community (Higher Education, Research) 230
Participation to a conference P1 - Charité: Leila Amini RegMed Forum, Berlin, November 25th, 2021 oral presentation: CRISPR-based immune cell therapies: Immunosuppressant-resistant T cells for improved adoptive T cell therapy Scientific Community (Higher Education, Research) + Industry 50
Brokerage event P1 - Charité: D.L.Wagner Collaboration Meeting: Integrated DNA Technologies - Datum fehlt noch Improving HDR in T cells    
Participation to a conference P1 - Charité: D.L. Wagner Virtual 1st Allogeneic cell therapies summit Europe, 18.01.-20.01.2022, online conference, UK Panel discussion with Dr. Matthias Herrath (Novo Nordisk) Industry, Scientific Community 100
Other P1 - Charité: D. L. Wagner ESGCT e-Seminar Series, live on 08.02.2022, Youtube video https://www.youtube.com/watch?v=q5D7sMKt53E Virus-free gene editing of T cells, talk Scientific Community (Higher Education, Research) >500
Participation to a conference P1 - Charité: Christina Iwert Cell Symposium - "Metabolites in Signalling and Disease", Lisboa (Portugal), 03.-05.04.2022 Poster presentation: The mitochondrial protein TCAIM inhibits metabolic reprogramming and effector T cell differentiation through regulation of VDAC2. Scientific Community (Higher Education, Research) 15
Brokerage event P1 - Charité: P. Reinke, M. Schmück-Henneresse Cooperation Meeting Janssen&Janssen, Berlin (Germany), 04.04.2022 Cell Therapy Industry ca. 10
Other P1 - Charité: P. Reinke, H. Schmidts, H.-D. Volk ReSHAPE - Steering Committee Meeting, virtual, 20.04.2022 Other 12
Brokerage event P1 - Charité: P. Reinke Follow-up Cooperation Meeting CellCopedia, Berlin (Germany), 21.04.2022 Development and marketing of medical technology for the selection of cells Other 2
Participation to an event Other than a conference or workshop P1 - Charité ReSHAPE Third Annual Meeting, 26.-27.04.2022 / virtual Meeting for all ReSHAPE Partners, presentation of the current status of the projects and partial results Scientific Community (Higher Education, Research) ca. 55
Brokerage event P1 - Charité: P. Reinke, H.-D. Volk Follow-up Cooperation Meeting Florabio, virtual, 04.05.2022 Cell media development Industry 5
Brokerage event P1 - Charité: P. Reinke Follow-up Cooperation Meeting AstraZeneca, virtual, 10.05.2022 Further steps - discussion on how to structure the collaboration Industry 3
Participation to a conference P1 - Charité: P. Reinke, DL Wagner, L. Amini, M. Schmück-Henneresse, J. Polansky, H.-D. Volk mini-Retreat Platform Immune System, Berlin (Germany), 11.05.2022 Presentation: results of laboratory work Scientific Community (Higher Education, Research) ca. 100
Organisation of a Conference P1 - Charité: M. Schmück-Henneresse (Organisator) mini-Retreat Platform Immune System, Berlin (Germany), 11.05.2022 Scientific Community (Higher Education, Research) ca. 100
Brokerage event P1 - Charité: P. Reinke Follow-up Cooperation Meeting AstraZeneca, virtual, 12.05.2022 Further steps - discussion on how to structure the collaboration Industry 5
Brokerage event P1 - Charité: P. Reinke, H.-D. Volk, M. Schmück-Henneresse, DL Wagner Cooperation Meeting, ProBioGen, Berlin (Germany), 07.06.2022 Cell therapy Industry 7
Participation to a conference P1 - Charité: P. Reinke, H.-D. Volk FOCIS Annual Meeting 2022, San Francisco (USA), 21.-24.06.2022 Scientific Community (Higher Education, Research) ca. 1.000
Participation to a conference P1 - Charité: P. Reinke, H.-D. Volk, L. Amini, J. Polansky, M. Schmück-Henneresse, DL Wagner BCRT Retreat, Berlin (Germany), 30.06.2022 Talk L. Amini - "Tac resistant CMV specific cell products"; talk M. Schmück-Henneresse; talk D.L. Wagner; talk J. Polansky Scientific Community (Higher Education, Research) ca. 50 ???
Brokerage event P1 - Charité: P.Reinke, A. Römhild, D. Kaiser Cooperation Meeting Sartorius, Berlin (Germany), 07.07.2022 Cell therapy Industry 10
Participation to a conference P1 - Charité: P. Reinke, H.-D. Volk IPLASS and COST SPRINT Action Joint Scientific Meeting, 02.-03.09.2023, Brescia (Italy) talk P. Reinke "Current scientific challenges associated to cell therapies"; talk H.-D. Volk "Cell product specification and biomarker monitoring in clinical trials" Scientific Community (Higher Education, Research) ca. 100
Brokerage event P1 - Charité: P. Reinke, DL Wagner Follow-up Cooperation Meeting Janssen&Janssen, virtual, 07.09.2022 CAR-T cells Industry 23
Participation to a conference P1 - Charité: J. Polansky Joint meeting of DGfI and ÖGAI, 07.-10.10.2022 Epigenetic control of T cell differentiation: From genome-wide signatures to local regulators and their targeted manipulation. Scientific Community (Higher Education, Research) ca. 600
Participation to a conference P1 - Charité: D.L. Wagner, J. Kath, W. Du ESGCT 29th Congress, 11.-14.10.2022, Edinburgh (UK) Poster presentations: "Gene editing of the CD3 epsilon locus enables generation of HLA-A2-specific regulatory T cells to prevent allo-rejection in solid organ transplantation", "CD247 gene editing as a novel platform technology for off-the-shelf Chimeric Antigen Receptor reprogrammed immune cells" Scientific Community (Higher Education, Research) 300
Participation to a conference P1 - Charité: J. Kath Synthego World CRISPR Day, 20.10.2022, virtual (youtube) Talk "CD3z(CD247) gene editing: a platform for off-the-shelf CAR reprogrammed immune cells" and panel discussion, talk live streamed (e.g. 3000 participants), talk >4000 views on Youtube General Public, Scientific Community >7000
Participation of activities organized jointly with Other EU Project(s) P1 - Charité: P. Reinke Meet the CTGCT - technologies in cell and gene therapy, 8.11.2022, virtual Talk P. Reinke "Current scientific challenges associated to cell therapies"; talk D.L. Wagner "Future in gene editing" Scientific Community (Higher Education, Research)
Brokerage event P1 - Charité: P. Reinke Follow-up Cooperation Meeting Sartorius, virtual, 12.01.2023 Cell therapy Industry 2
Participation to a conference P1 - Charité: D. L. Wagner 2nd Allogeneic cell therapies summit Europe, 30.01.-02.02.2023, London, UK Talk "CAR-T Cells Generated by Non-Viral Gene Editing - From Autologous to Allogeneic Approaches" Industry, Scientific Community 100
Participation to a conference P1 - Charité: J. Kath, W. Du 5th European CAR T-cell Meeting, 9.-11.2.2023, Rotterdam (NL) Poster presentations: "Gene editing of the CD3 epsilon locus enables generation of HLA-A2-specific regulatory T cells to prevent allo-rejection in solid organ transplantation", "CD3z (CD247) gene editing - a virus-free platform for next generation CAR therapeutics" Scientific Community (Higher Education, Research) 150
Other P1 - Charité: D. L. Wagner Immuntherapy Meeting, Berlin, 15.02.2023, virtual Non-viral gene editing for cell therapy - from autologous to allogeneic approaches Scientific Community (Higher Education, Research) 30
Press event P1 - Charité: M. Schmück-Henneresse Press Workshop - Gene Therapy - Hope for Rare Diseases?, 15.02.2023, Berlin T cells genetically engineered with CRISPR-Cas for immunotherapy. Media representatives 30
Participation of activities organized jointly with Other EU Project(s) P1 - Charité: P. Reinke Widening in Horizont Europa - Insights into the 2023/2024 work program and exchange with successful projects, virtual, 24.02.2023 P. Reinke "ReSHAPE project presentation" Scientific Community (Higher Education, Research) ca. 100
Participation to a conference P1 - Charité: M. Schmück-Henneresse Genome Editing to Treat Humans Diseases Conference, 14.03.2023, Granada (Spain) Experimental immunotherapy Scientific Community (Higher Education, Research) 200
Participation to a conference P1 - Charité: E. Fritsche Advanced Therapies 2023, 14.-15.03.2023, London (UK) Networking to gain attention for our Treg-associated ReShape projects in an industry-academic driven conference and exhibition, mainly driven by industry bringing together business partner for interaction across the entire value chain of cell and gene therapy development, i.e. pharma, biotech and start-up companies as well as researchers, clinicians, academics, HTAs, payers and regulators Industry & academia 2000+
Organisation of a Conference P1 - Charité: P. Reinke, H.-D. Volk "Driving Academic Translation of Cell and Gene Therapies", Berlin (Germany), 30.-31.03.2023 P. Reinke "ReSHAPE project presentation"; HD Volk "Measures of Translation"; DL Wagner "Gene editing Strategies" Scientific Community (Higher Education, Research) ca. 100
Brokerage event P1 - Charité: P. Reinke, L. Amini, H.-D. Volk, M. Schmück-Henneresse Follow-up Cooperation Meeting ProBioGen, Berlin (Germany) 04.05.2023 Cell therapy Industry 10
Other P1 - Charité: D. L. Wagner Seminar Series on Modern Human Genetics, 9.5.2023, University of Göttingen, Germany Talk: The evolving toolbox of CRISPR-Cas gene editing: from modelling mutations to the next-generation of cell and gene therapies Scientific Community (Higher Education, Research) 30
Other P1 - Charité: M. Schmück-Henneresse Immuntherapy Meeting, Berlin, 16.06.2023, hybrid (virtual and at Charité Campus Virchow Klinikum, Berlin Germany) Experimental immunotherapy Scientific Community (Higher Education, Research) 50
Participation to a conference P4 - UOXF: Fadi Issa "Nanostring EU Summits: Crosstalk" 23 Oct 2019, Birmingham, UK "How nanoString can enrich transplant studies" - talk Scientific Community (Higher Education, Research) 100
Participation to a conference P4 - UOXF: Fadi Issa International Transplantation Science Meeting, 10 - 13th November 2019, Clearwater Beach, Florida, USA   Scientific Community (Higher Education, Research) 200
Participation to an event other than a conference or workshop P4 - UOXF: Joanna Hester RESTORE: 1st Advanced Therapy Science Meeting, Berlin (Germany), 25.-26.11.2019 "The TWO Study – A Phase II Trial of Regulatory T Cell Therapy in Renal Transplantation" - poster Scientific Community (Higher Education, Research) 400
Participation to a conference P4 - UOXF: Fadi Issa The 4th International Workshop on Clinical Tolerance Update on the Oxford/London ONE and TWO Studies Scientific Community (Higher Education, Research) 100
Participation to a conference P4 - UOXF: Fadi Issa Nanostring EU Summits: Crosstalk Birmingham (UK), 23.10. 2019 Talk: "How nanoString can enrich transplant studies" Scientific Community (Higher Education, Research) 100
Participation to a conference P4 - UOXF: Fadi Issa International Transplantation Science Meeting, Clearwater Beach, Florida (US) 10 -13.11.2019 Scientific Community (Higher Education, Research) 200
Participation to an event Other than a conference or workshop P4 - UOXF: Joanna Hester RESTORE: 1st Advanced Therapy Science Meeting, Berlin (Germany), 25.-26.11.2019 Poster presentation "The TWO Study - A Phase II Trial of Regulatory T Cell Therapy in Renal Transplantation" Scientific Community (Higher Education, Research) 400
Participation to a conference P4 - UOXF: Fadi Issa The 4th International Workshop on Clinical Tolerance, Pittsburgh, Pennsylvania (US), 5-6.09.2019 Update on the Oxford/London ONE and TWO Studies Scientific Community (Higher Education, Research) 100
Participation to a conference P4 - UOXF: Fadi Issa Nanostring meeting, San Diego, USA "Adavancing transplantation with nCounter and GeoMx" - talk Scientific Community (Higher Education, Research) 100
Participation to a conference P4 - UOXF: Fadi Issa FOCIS 2023, 20-23.6.2023 Spatial profiling of lungs, livers, and kidneys Scientific Community (Higher Education, Research) 100
Participation to a conference P4 - UOXF: Fadi Issa CAMS-COI Conference, 1-5.6.2023 Cell therapy in transplantation: advances Scientific Community (Higher Education, Research) 100
Participation to a conference P4 - UOXF: Fadi Issa Ajmera Transplant Conference, 26.5.2023 Regulatory T cell therapy in transplantation Scientific Community (Higher Education, Research) 150
Participation to a conference P4 - UOXF: Fadi Issa Nantes Seminar Series, 13.6.2023 Spatial profiling: application to transplantation Scientific Community (Higher Education, Research) 70
Participation to an event other than a conference or workshop P5 - Markus Templin Virologisch-wissenschaftliches Kolloquium University Clinic Tübingen Germany Talk: Multiplexed Immunoassays - Characterisation of Immune Cells Scientific Community (Higher Education, Research) 60
Participation to a conference P5 - NMI: Markus Templin Analytica 2020 München (Germany) 19.-23.10.2020 "Profiling of cellular signalling pathways using a multiplexed Western Blot" - talk Scientific Community (Higher Education, Research) 400
Participation to an event Other than a conference or workshop P5 - Markus Templin Virologisch-wissenschaftliches Kolloquium University Clinic Tübingen Germany Talk: Multiplexed Immunoassays - Characterisation of Immune Cells Scientific Community (Higher Education, Research) 60
Participation to a conference P5 - NMI: Markus Templin Analytica 2020 München (Germany) 19.-23.10.2020 "Profiling of cellular signalling pathways using a multiplexed Western Blot" - talk Scientific Community (Higher Education, Research) 400
Participation to an event other than a conference or workshop P6 - CTC: Ilaria Santeramo CGTC's regular lab meeting, CGTC, 21 August 2019 Internal talk Scientific Community (Higher Education, Research) 50
Participation to an event Other than a conference or workshop P6 - CTC: Ilaria Santeramo CGTC's regular lab meeting, CGTC, London (UK), 21.08.2019 Internal talk Scientific Community (Higher Education, Research) 50
Web-site P6 - CTC CGTC's collaboration website, 15.04.2019 https://ct.catapult.org.uk/how-we-work/our-collaborators General Public
Participation to a conference P6 - CTC: Davide Grandolfo Treg summit, Boston (US), 19-22.-5.2019 Attendance Scientific Community (Higher Education, Research) 100
Participation to a conference P6 - CTC: Ilaria Santeramo 2nd International Conference on Lymphocyte Engineering (ICLE 2019), London (UK) 13-15.09.2019 Attendance Scientific Community (Higher Education, Research) 100
Participation to a workshop P6 - CTC: Tristan Thwaites Webinar Phacilitate Exchange, 11.12.2019 Talk, title: 'Is a non-viral gene editing approach the answer to developing next generation advanced therapies?' Scientific Community (Higher Education, Research) 100
Participation to a conference P6 - CTC: Tristan Thwaites American Society of Gene and Cell therapy, Virtual Cell and Gene Therapy Symposium, 07.05.2020 Talk, title: 'Non-viral gene delivery - supporting the next genration of gene edited cell therapies' Scientific Community (Higher Education, Research) 1.000
Participation to a conference P7 - TissUse WC11 Virtual Congress, 23-27.08.2021 Oral presentation, title: Establishment of a multi-organ-chip platform to replace animal transplant models for preclinical evaluation of Treg cell therapies Scientific Community (Higher Education, Research) 100
Participation to a conference P7 - TissUse WC11 Virtual Congress, 23-27.08.2021 Oral presentation, title: Establishment of a multi-organ-chip platform to replace animal transplant models for preclinical evaluation of Treg cell therapies Scientific Community (Higher Education, Research) 100
Participation to a conference P7 - TissUse Isabell Durieux 11th BSRT Symposium 2020, December 2 - 4 Establishment of a human multi-organ-chip platform to replace animal transplant models for preclinical evaluation of Treg cell therapies Scientific Community (Higher Education, Research) 150
Participation to a conference P7 - TissUse Uwe Marx ILAR NASEM Workshop, 2021, January 20, virtual Emulating human organ interactions on a universal multi-organ-chip platform Regulatory Science 250
Brokerage event P7 - TissUse Isabell Durieux BIONNALE 2021, Berlin (Germany), May 12 Kidney transplantation in a chip Other >900
Participation to a conference P7 - TissUse Isabell Durieux WC11 2021, August 23 - 27 Establishment of a human multi-organ-chip platform to replace animal transplant models for preclinical evaluation of T cell therapies (talk) Scientific Community (Higher Education, Research) 150
Participation to a conference P7 - TissUse Uwe Marx WC11 2021 August 24, virtual Science, ethics and acceptance of human microphysiological systems - an ultimate alternative to testing in laboratory animals and human volunteers Scientific Community (Higher Education, Research) 150
Participation to a conference P7 - TissUse Eva Dehne WC11 2021, August 23 - 27 Biology-inspired microphysiological systems: The asset of multi-organ co-cultures Scientific Community (Higher Education, Research) 150
Participation to a conference P7 - TissUse Uwe Marx CBER FDA Training Course , 2022 May 24, virtuell Microfluidic-Based Analytical Technologies, Modul Microphysiological systems FDA Zulassungsbeamte 80
Participation to a conference P7 - TissUse Isabell Durieux MPS World Summit 2022, May 30 - June 3 Establishment of a human multi-organ-chip platform to replace animal transplant models for preclinical evaluation of T cell therapies (talk) Scientific Community (Higher Education, Research) 150
Brokerage event P7 - TissUse Reyk Horland BIO 2022, June 13-19 Partnering Pitch Industry 4.000
Participation to a conference P7 - TissUse Isabell Durieux ISSCR 2022, June 15 - 18 Establishment of an autologous, human multi-organ-chip platform for evaluation of cell therapies (poster) Scientific Community (Higher Education, Research) 50
Brokerage event P7 - TissUse Reyk Horland BIO Japan 2022, October 12-14 Partnering Pitch Industry 1.200
Brokerage event P7 - TissUse Reyk Horland BIO Europe 2022, October 24-26 Partnering Pitch Industry 3.000
Brokerage event P7 - TissUse Reyk Horland BIO 2023, June 5-8 Partnering Pitch Industry 5.000
Participation to a conference P7 - TissUse Uwe Marx MPS World Summit 2023, June 26-30 Integrating human organoids into organismoids - how to achieve human body homeostasis in vitro? Scientific Community (Higher Education, Research) 1.000
Participation to a conference P7 - TissUse Isabell Durieux WC12 2023, August 27 - 31 Development towards an Organ-on-the-Chip technology for complex in vitro testing of T cell products Scientific Community (Higher Education, Research) 150
Web-site P9 - INNACTA RESHAPE Website Regular Updates   Other 1.000
Web-site P9 - INNACTA RESHAPE Official Website- develop and programming https://www.reshape-h2020.eu/ General Public 1.000
Web-site P9 - INNACTA Innovation Acta website, mention to the Project https://www.innovationacta.eu/projects General Public 1.000
Organisation of a Conference P9 - INNACTA RESHAPE Kick off meeting, Berlin (Germany), 7-8.02.2019 https://www.reshape-h2020.eu/#events-area Other 50
Other P9 - INNACTA Graphical material for RESHAPE Kick off meeting, Berlin (Germany), 7-8.02.2019 https://www.reshape-h2020.eu/#events-area Other 50
Organisation of a Conference P9 - INNACTA RESHAPE First Annual meeting, Berlin (Germany 2020), 23-24.01.2020 https://www.reshape-h2020.eu/#events-area Other 50
Other P9 - INNACTA Graphical material for RESHAPE First Annual meeting, Berlin (Germany 2020), 23-24.01.2020 https://www.reshape-h2020.eu/#events-area Other 50
Web-site P9 - INNACTA RESHAPE Website Regular Updates Other 1.000
Participation to a conference P10 - Ignacio Anegon FOCISed in South East Asia 1st Annual Course: Advances in Immunology, Immune Monitoring, and Immunotherapy. Jaipur, India. March 26-29, 2019. talk Scientific Community (Higher Education, Research) 120
Participation to a conference P10 - UN Ignacio Anegon Latin American Society for Immunology and French Society for Immunology joint meeting. FOCIS annual meeting. Cancun, Mexico. June 18th 2019. I. Anegon. CD8+ Tregs in transplantation. talk Scientific Community (Higher Education, Research) 100
Participation to a conference P10 - UN Carole Guillonneau 3) Day of Immunotechnologies, Institut Gustave Roussy, Paris, France. 26th Septembre 2019. C. Guillonneau, Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases talk Scientific Community (Higher Education, Research) 150
Participation to a conference P10 - UN Carole Guillonneau ThymE: T cell and thymus biology, Rehovot, Israel 19-23 May 2019. C. Guillonneau, Anti-CD45RC to eliminate Teffs and induce Tregs in APECED disease. talk    
Participation to a conference P10 - UN What’s up in Immunotherapy, 31st January 2019, C. Guillonneau, Nantes, France. Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases. talk    
Participation to a conference P10 - UN Séverine Bézie ThymE: T cell and thymus biology. Rehovot, Israel, 19-23 May 2019. S. Bézie (poster) Human CD8+ Treg mediated inhibition of GVHD and human skin rejection in NSG mice.      
Participation to a conference P10 - UN Carole Guillonneau Annual Meeting of the French Society for Immunology, Nantes, France. 12-14rd November 2019 oral presentation, title: Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases.    
Participation to a conference P10 - UN Séverine Bézie Annual Meeting of the French Society for Immunology, Nantes, France. 12-14th November 2019 Oral presentation, title: Human CD8+ Treg suppress human skin rejection and GVHD in NSG mice.    
Organisation of a Conference P10 - UN Ignacio Anegon 22e NAT-IGO Congress: "New horizons in immunotherapy" (31/05-01/06-2021) Scientific Committe Scientific Community (Higher Education, Research) 250
Participation to a conference P10 - UN Ignacio Anegon 5th French international symposium on CAR T-cell therapy (CAR T Day 2021) that took place in Lille, France, on September 2-4, 2021. Invited talk. CAR Treg in organ transplantation, GVHD and autoimmunity. Scientific Community (Higher Education, Research) 300
Participation to a conference P10 - UN Ignacio Anegon 3rd Transplantchild Workshop. Madrid. November 11th, 2021. Invited talk. A new mAb tolerogenic therapy in organ transplantation, GVHD and genetic autoimmune diseases. Scientific Community (Higher Education, Research) 100
Organisation of a workshop P10 - UN Ignacio Anegon 2nd FOCIS Goes South Meeting. Santiago de Chile (virtual). November 11th, 2021 Invited talk. Anti-CD45RC mAb therapy tolerogenic therapy. Scientific Community (Higher Education, Research) 750
Organisation of a workshop P10 - UN Ignacio Anegon Inaugural FOCIS Advanced Course in Translational and Clinical Immunology. China (on line). December 4h, 2021. Ornad and bone marrow transplantation. Scientific Community (Higher Education, Research) 1.800
Participation to a conference P10 - UN Carole Guillonneau FOCIS 2020, 28-31.10.2020 e-oral "Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases." Scientific Community (Higher Education, Research) 100
Participation to a workshop P10 - UN Carole Guillonneau TLJ2.0 organized by the European Society for Organ Transplantation (ESOT) e-oral presentation, title: "Cell therapy using CD8+Tregs in human transplantation" Scientific Community (Higher Education, Research) 100
Participation to a conference P10 - UN Carole Guillonneau TTS 2020 Virtual Congress, 14-16.09.2020 e-oral "Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases." Scientific Community (Higher Education, Research) 3.500
Organisation of a Conference P10 - UN Carole Guillonneau 22e NAT-IGO Congress: "New horizons in immunotherapy" (31/05-01/06-2021) Chairwoman Scientific Community (Higher Education, Research) 250
Participation to a conference P10 - UN Séverine Bézie Annual Meeting of the French Society for Immunology, Nantes (France), 12-14.11.2019 Oral presentation, title: Human CD8+ Treg suppress human skin rejection and GVHD in NSG mice. Scientific Community (Higher Education, Research) 500
Participation to a conference P10 - UN Séverine Bézie TTS 2020 Virtual Congress, 14-16.09.2020 e-Poster presentation, title: "Cell therapy using CD8+Tregs in human transplantation" Scientific Community (Higher Education, Research) 3.500
Participation to a conference P10 - UN Séverine Bézie FOCIS 2020, 28-31.10.2020 e-oral and e-poster presentation, title: "Cell therapy using CD8+Tregs in human transplantation" Scientific Community (Higher Education, Research) 100
Participation to a conference P10 - Ignacio Anegon FOCISed in South East Asia 1st Annual Course: Advances in Immunology, Immune Monitoring, and immunotherapy. Jaipur (India) 26-29.03. 2019 talk Scientific Community (Higher Education, Research) 120
Participation to a conference P10 - Ignacio Anegon 14th Meeting of the International Society for Transgenic Technologies. Kobe (Japan) 8-10 April, 2019. invited talk "Generation of genome edited rats for the analysis of immune responses" Scientific Community (Higher Education, Research) 500
Participation to a conference P10 - UN Ignacio Anegon Latin American Society for Immunology and French Society for Immunology joint meeting. FOCIS annual meeting. Cancun (Mexico) 18.06.2019. Invited talk. CD8+ Tregs in transplantation. Scientific Community (Higher Education, Research) 100
Participation to a conference P10 - UN Carole Guillonneau Day of Immunotechnologies, Institut Gustave Roussy, Paris (France), 26. 09.2019 invited talk "Generation of genome edited rats for the analysis of immune responses" Scientific Community (Higher Education, Research) 150
Participation to a conference P10 - UN Carole Guillonneau ThymE: T cell and thymus biology, Rehovot (Israel) 19-23.05.2019 invited talk "Anti-CD45RC to eliminate Teffs and induce Tregs in APECED disease" Scientific Community (Higher Education, Research) 250
Participation to a conference P10 - UN Carole Guillonneau What’s up in immunotherapy, Nantes (France) 31.01.2019 Invited talk "Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases." Scientific Community (Higher Education, Research) 100
Participation to a conference P10 - UN Séverine Bézie ThymE: T cell and thymus biology. Rehovot (Israel)19-23.05.2019 Poster presentation "Human CD8+ Treg mediated inhibition of GVHD and human skin rejection in NSG mice" Scientific Community (Higher Education, Research) 250
Participation to a conference P10 - UN Carole Guillonneau Annual Meeting of the French Society for Immunology, Nantes (France). 12-14.11.2019 oral presentation, title: Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases. Scientific Community (Higher Education, Research) 500
Participation to a conference P10 - UN Séverine Bézie Annual Meeting of the French Society for Immunology, Nantes (France), 12-14.11.2019 Oral presentation, title: Human CD8+ Treg suppress human skin rejection and GVHD in NSG mice. Scientific Community (Higher Education, Research) 500
Organisation of a Conference P10 - UN Ignacio Anegon 22e NAT-IGO Congress: "New horizons in immunotherapy" (31/05-01/06-2021) Scientific Committe Scientific Community (Higher Education, Research) 250
Participation to a conference P10 - UN Ignacio Anegon 5th French international symposium on CAR T-cell therapy (CAR T Day 2021) that took place in Lille, France, on September 2-4, 2021. Invited talk. CAR Treg in organ transplantation, GVHD and autoimmunity. Scientific Community (Higher Education, Research) 300
Participation to a conference P10 - UN Ignacio Anegon 3rd Transplantchild Workshop. Madrid. November 11th, 2021. Invited talk. A new mAb tolerogenic therapy in organ transplantation, GVHD and genetic autoimmune diseases. Scientific Community (Higher Education, Research) 100
Organisation of a workshop P10 - UN Ignacio Anegon 2nd FOCIS Goes South Meeting. Santiago de Chile (virtual). November 11th, 2021 Invited talk. Anti-CD45RC mAb therapy tolerogenic therapy. Scientific Community (Higher Education, Research) 750
Organisation of a workshop P10 - UN Ignacio Anegon Inaugural FOCIS Advanced Course in Translational and Clinical Immunology. China (on line). December 4h, 2021. Ornad and bone marrow transplantation. Scientific Community (Higher Education, Research) 1.800
Participation to a conference P10 - UN Carole Guillonneau FOCIS 2020, 28-31.10.2020 e-oral "Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases." Scientific Community (Higher Education, Research) 100
Participation to a workshop P10 - UN Carole Guillonneau TLJ2.0 organized by the European Society for Organ Transplantation (ESOT) e-oral presentation, title: "Cell therapy using CD8+Tregs in human transplantation" Scientific Community (Higher Education, Research) 100
Participation to a conference P10 - UN Carole Guillonneau TTS 2020 Virtual Congress, 14-16.09.2020 e-oral "Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases." Scientific Community (Higher Education, Research) 3.500
Organisation of a Conference P10 - UN Carole Guillonneau 22e NAT-IGO Congress: "New horizons in immunotherapy" (31/05-01/06-2021) Chairwoman Scientific Community (Higher Education, Research) 250
Participation to a conference P10 - UN Séverine Bézie Annual Meeting of the French Society for Immunology, Nantes (France), 12-14.11.2019 Oral presentation, title: Human CD8+ Treg suppress human skin rejection and GVHD in NSG mice. Scientific Community (Higher Education, Research) 500
Participation to a conference P10 - UN Séverine Bézie TTS 2020 Virtual Congress, 14-16.09.2020 e-Poster presentation, title: "Cell therapy using CD8+Tregs in human transplantation" Scientific Community (Higher Education, Research) 3.500
Participation to a conference P10 - UN Séverine Bézie FOCIS 2020, 28-31.10.2020 e-oral and e-poster presentation, title: "Cell therapy using CD8+Tregs in human transplantation" Scientific Community (Higher Education, Research) 100
Participation to a conference P10 - UN Séverine Bézie 23th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), Boston, USA, 2023 3 poster presentations: "Transfer of CD8+T regulatory cells GMP manufacturing for clinical trial in kidney transplanted patients"; "Reprogramming CD8+FOXP3+Treg to deal with an inflamed environment."; " ;Combining human CD4+ and CD8+ Treg to inhibit experimental acute GVHD" Scientific Community (Higher Education, Research) 1.000
Participation to a conference P10 - UN Carole Guillonneau 22th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), San Francisco, USA, 2022 oral presentation "Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases." Scientific Community (Higher Education, Research) 800
Participation to a conference P10 - UN Carole Guillonneau 29th International Congress of the Transplantation Society (TTS), Buenos Aires, Argentina, 2022 Chair and TTS SFT award recipient Scientific Community (Higher Education, Research) 3.500
Participation to a conference P10 - UN Carole Guillonneau EFI 2023, Nantes 1 invited plenary presentation: Advancing Treg cell therapies to the clinic Scientific Community (Higher Education, Research) 3.000
Participation to a conference P10 - UN Carole Guillonneau International Transplantation Society, Niagara On the Lake, Canada, 2023 Chair and 1 oral presentation: Single-cell transcriptomic analysis to further delineate human CD8+ T regulatory cell subsets Scientific Community (Higher Education, Research) 200
Participation to a conference P10 - UN Carole Guillonneau 23th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), Boston, USA, 2023 1 poster presentation: Anti-CD45RC mAb efficiently prevent experimental rheumatoid arthritis (RA) Scientific Community (Higher Education, Research) 1.000
Participation to a conference P10 - UN Céline Sérazin 22th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), San Francisco, USA, 2022 1 poster presentation : expression of TNFR2 and CD29 define a highly suppressive subset of human CD8+ regulatory T cells Scientific Community (Higher Education, Research) 800
Participation to a conference P10 - UN Céline Sérazin 29th International Congress of the Transplantation Society (TTS), Buenos Aires, Argentina, 2022 1 oral presentation : Delineating human CD8+ regulatory T cells heterogeneity Scientific Community (Higher Education, Research) 3.500
Participation to a conference P10 - UN Céline Sérazin 23th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), Boston, USA, 2023 1 poster presentation : single cell transcriptomic analysis further delineates human CD8+ T regulatory cell subsets Scientific Community (Higher Education, Research) 1.000
Organisation of a Conference P10 - UN Ignacio Anegon 23th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), Boston, USA, 2023 Scientific Community (Higher Education, Research) 1.000

ReSHAPE PRESS RELEASES


Press releases and other dissemination material will be available soon.